FDA gives full approval to Pfizer Covid Paxlovid treatment for high-risk adults
Pills for the treatment of coronavirus disease (COVID-19) are shown in boxes, at Misericordia Hospital in Grosseto, Italy, February 8, 2022. Jennifer Lorenzini | Reuters The Food and Drug Administration on Thursday granted full approval to Pfizer’s antiviral Covid pill, Paxlovid, for adults at high risk of contracting the virus. Paxlovid is specifically recommended for …
FDA gives full approval to Pfizer Covid Paxlovid treatment for high-risk adults Read More »